Bio-Rad Laboratories
Federal opportunity from Department of Health. Place of performance: FL. Response deadline: Jul 09, 2026.
- Source
- Open on official portal →
- Solicitation
- 584170b46cb48f689d283deb3fc61d5d
- Performance
- Tallahassee, FL
- Response
- Jul 09, 2026, 06:30 PM UTC
Point of Contact
Agency & Office
Applicable wage determinations
Best public WD match for the notice location and scope.
View more WD detail3 more WD matches and 18 more rate previews.↓
Description
<p>The FDOH BPHL has a need to purchase a FDA approved confirmatory assay system to perform HIV-1/HIV-2 Supplemental differentiation assay testing to confirm HIV infection in patients testing positive on an initial screen. The assay must be able to test whole blood, serum, plasma, and in-house validated oral fluid to conform to the CDC 2014 HIV Diagnostic Algorithm guidelines. In accordance with Chapter 60A-1.045, Florida Administrative Code, the Florida Department of Health, BPHL, requests authorization to purchase, as a single source, the Bio-Rad Laboratories Geenius™ System assays and controls.</p>
Pricing and bid posture
Contractor-side estimate from visible notice metadata, NAICS/PSC, contract type, schedule hints, and BidPulsar workpaper assumptions. Not an IGCE, incumbent price, award value, or government budget.
This advisory bid range is visible page text for contractors and search engines: it summarizes the modeled floor, target, and premium bid posture for this solicitation.
Market snapshot
Baseline awarded-market signal across all contracting (sample of 400 recent awards; refreshed periodically).
Files
Files size/type shown when available.
BidPulsar Analysis
A practical, capture-style breakdown of fit, requirements, risks, and next steps.
Service match
Optional support routes matched to this notice after the core solicitation details.
Related hubs & trends
Navigate the lattice: hubs for browsing, trends for pricing signals.